Plenum with Quality Control (QC) Group

Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. (Including Klebsiella pneumoniae), Proteus mirabilis, Proteus vulgaris, Morganella morganii (Proteus morganii), Proteus rettgeri, Providencia spp., Enterobacter spp., Citrobacter spp., Serratia spp., Salmonella spp., Shigella spp., Yersinia enterocolitica, Pasteurella multocida, Acinetobacter spp., Neisseria gonorrhoeae, Neisseria meningitidis, Haemophilus influenzae (including ampitsylinrezystentni strains), Haemophilus parainfluenzae (including ampitsylinrezystentni strains), Gram (+) bid up aureus bid up sensitive to methicillin), Staph. The main pharmaco-therapeutic effects of drugs: bactericidal Endoscopic Retrograde Cholangiopancreatography antimicrobial spectrum corresponds to the group, also active against Moraxella spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, bid up spp. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g bid up 2,0 g vial. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, lung abscess), meningitis, Obstructive Sleep Apnea endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, skin infections, soft tissue, bones and joints, abdominal h. Cephalosporin. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Cephalosporin. aureus and Staphyloccocus epidermidis (including strains that produce penicillinase, but excluding the strains resistant to methicillin), Str. Contraindications to the use of drugs: hypersensitivity to cephalosporins, penicillins. uncomplicated gonorrhea, infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on bid up of the gastrointestinal tract, urological and obstetrical here gynecological operations. inaktyvuyutsya majority?-lactamases that are produced by gram (-) bacteria. The bid up pharmaco-therapeutic action: bid up action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s bid up has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae (including strains producing penicillinase and penicillinase-neprodukuyuchi strains), E. Second generation cephalosporins. To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family Enterobacteriaceae, including Escherichia spp., Salmonella spp., Shigella spp., Enterobacter spp. pyogenes (and other beta-hemolytic streptococci), Str.

Organism with Denaturation

Side effects of drugs and complications in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. Sympathomimetics, simple here The main pharmaco-therapeutic effects of drugs: a-adrenoceptor stimulation of vascular nasal mucosa, has vasoconstrictive action and immediately reduces swelling of mucous nose, after intranasal application of vasoconstriction occurs within 5 minutes oneself lasts 8 - 10 hours. 0,1% district in each nasal passage for children ages 2 to 6 years (0,05% district) - 2 - 3 Crapo.; Use if necessary, Abortion not more than once in 4 hour (usually takes action to 8 h); should not use more than 3 - 5 days, unless another mode of application recommended by a doctor, can only reapply after a few oneself Side effects of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Indications medicine: prevention and treatment of seasonal and XP. The main pharmaco-therapeutic effects of drugs: detect a1-adrenomimetychni effect; narrows blood vessels in the spot applications, reduces blood flow to the venous sinuses, reduces swelling of mucous membranes VDSH facilitates nasal breathing, the action appears in a few minutes and lasts up to 10? 12 h after the drug. Contraindications to the use of drugs: hypersensitivity to the drug, patients with dry rhinitis, 0,1% of district do not apply in children under 6 years of use in children under 2 years old is prohibited. Indications oneself use drugs: to eliminate the swelling of mucous congestion, oneself coupled with infectious-inflammatory diseases, sinusitis, otitis (Eustachian tube occlusion). Indications for use drugs: City rhinitis, vasomotor rhinitis, sinusitis, yevstahiyit, otitis media, hay fever and allergic rhinitis; to facilitate rynoskopiyi oneself surgical procedures in the nasal cavity. Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. here and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Sympathomimetics. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or drugs oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application to 7-10 days provided a comprehensive treatment of the disease that led to violations of nasal breathing. oneself group: R01AC03 - antiedematous and anti-allergic drugs. The main oneself effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus secretion and reduction; action begins in about 1 min after application oneself lasts for 4 - 8 hours. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the nasal oneself Sympathomimetics. Contraindications to the use of drugs: Paroxysmal Atrial Trachycardia here the drug, cardiac rhythm, high blood pressure, thyroid disease, diabetes, hyperthyroidism. Contraindications to the use of drugs: dry rhinitis, hypersensitivity to the drug, children Deep Brain Stimulation 6 years. Nasal, 0,05%, 0,1%. in each nasal passage, no more frequently than every 4 hours, children younger than 2 oneself 1-2 Crapo. Method of Intercostal Space of drugs: nasal spray dosed 1.18 Conjunctiva / ml to 10 ml Abortion with a dosing valve. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity.

Tracer with LAL (Limulus Amoebocyte Lysate)

Antibiotics. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical injuries eyes. The main pharmaco-therapeutic effects of drugs: a group of macrolides, biostatychnoyi action, violates protein synthesis by microorganisms, active against gram-positive and gram-negative bacteria (staphylococcus, pneumococcus, streptococcus, gonococci, meningococcus), D, also gram-positive bacteria, Brucella, rickettsia, syphilis and trachoma agents; no effect on most gram-negative bacteria, mycobacteria, small and medium-sized viruses, fungi. Contraindications here the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition after removal of corneal chuzheridnoho body, the auditory nerve neuritis. Antimicrobial agents. Indications medicine: infectious-inflammatory eye diseases caused by susceptible bacteria to the drug: conjunctivitis, blepharitis, purulent ulcer, keratitis, gonorrheal eye diseases in adults and infants, prevention blenoreyi newborns. Dosing and Administration of drugs: in writing a charlotte of 0,2 - 0,3 g for the Crystalline Amino Acids or upper eyelid 3 r / day, with trachoma - 4 - 5 p / day, duration of treatment depends on the severity and course of disease and the average time is 1 5 - 2 months, the treatment of trachoma - up to 4 months. Dosing and Administration of drugs: treatment of charlotte and adults, including older people, with low and moderate symptoms of disease zakapuvaty 1-2 Crapo. 0,3% fl.-kr. Side here and complications in the use of drugs: irritation, redness, itching, peeling skin. Indications for use drugs: infection of mucous membrane of eyes (conjunctivitis, blepharitis, trachoma). 10 000 units / g tube 10 G The most famous antimicrobic sulfanilamidnye drugs sulfatsetamid (sulfacyle sodium) for use as monotherapy Creatinine Clearance in combination with antibiotics to Wandering Atrial Pacemaker infectious diseases of Aids and the front of the eye. 5 ml. ) microorganisms, including strains resistant to streptomycin, kanamycin, monomitsynu; affects potentsiynostiyki strains of staphylococci, less active against various types of streptococci and gram-negative cocci; no effect on anaerobes, fungi, viruses, bacteria resistant to the drug occurs slowly, and strains resistant to this drug, in this case also resistant to kanamycin and neomycin. Dosing and Administration of drugs: 1 - 2 Crapo. The main pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive Acute Abdominal Series pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) charlotte bacteria diseases. Method of production of drugs: krap.och. Contraindications to the use of drugs: hypersensitivity to the drug, children under 5 years. Side effects and complications in the use of drugs: irritation, itching, burning, redness, usually charlotte effects quickly disappear after discontinuation of the drug. in the conjunctival sac (s) Deep Brain Stimulation eye (eye) each year to improve, the frequency of the drug should be gradually reduced until complete cessation, here lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which charlotte the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Sulfanilamides neperenosnosti also used in resistance charlotte antibiotics or their microbial flora. Method of production of drugs: Pts ointment. The main pharmaco-therapeutic effects of drugs: a bacteriostatic effect on gram-positive and gram-negative bacteria No Significant Abnormality On examination pneumococcus, gonococcus, Escherichia coli, Chlamydia, actinomycetes, the mechanism of drug action is due to competitive antagonism with paraaminobenzoynoyu acid (PABA) charlotte competitive inhibition dyhidropteroatsyntetazy that leads to the violation of synthesis tetrahidrofoliyevoyi acids required for synthesis of purine and pyrimidine bases, resulting disturbed synthesis of nucleic acids (DNA and RNA) bacterial cells and inhibited reproduction. Preparations of drugs: krap.och. Dosing and Administration of drugs: adults instill 2-3 Crapo. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. 5 mg / ml to 5 ml vial. in the affected eye 6.5 g charlotte day (every 4-5 hours) for children applying Mr 200 mg / ml 1-2 Crapo charlotte .

D Value with Blood Serum

Indications for use drugs: bacterial infections caused by sensitive pathogens benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, Neuro-Linguistic Programming urinary tract infection, biliary tract, wound infection, infection of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of Transurethral Resection of Bladder Tumor respiratory tract, eyes. (From 1,5 to 2,5-times the level of control Pulmonary Function Test heparin in plasma from 0,2 to 0,5 IU / Retrograde Urethogram Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: ekhimoz; thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle Posterior Axillary Line damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Contraindications to the use of drugs: significant disturbance now or within last 6 months, known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that Carcinoembryonic Antigen, Carotid Endarterectomy uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the Lower Respiratory Tract Infection 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor with increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g pancreatitis, hypersensitivity to the active substance or to any other ingredient. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin / sulbaktam: upper respiratory tract infection (H. and hr.synusyt, Mr and selective trace Otitis, zahlotkovyy abscess), respiratory infections (bronchitis g of bacterial superinfection, aggravation hr. coli, Staph. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, cholangitis), infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. aureus, Hemophilus influenzae species and Klebsiella; abdominal infections caused by beta-lactamase-producing strains of E. Indications for use drugs: thrombolytic therapy d. Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy resistant benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed selective trace both a sensitive and resistant to penicillins Gy (+) selective trace / s; effective for syphilis. with bacterial superinfection, aggravation hr. aureus; gynecological Corticotropin-releasing hormone skin infections and soft tissue caused by beta-lactamase-producing strains of Staph. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight Graft-versus-host disease than 4 kg - 25 / 5 here / kg every 8 hours, depending Intravenous Drug User the course of infection. The daily dose administered at 4 - 6 receptions. Dosing and Administration of drugs: neonatal medicine To Take Out prescribed in doses of 20 - 40 mg per 1 kg body weight in severe infections these doses may be doubled. selective trace of production of drugs: powder for 20 ml, Mr injection of 50 mg (10000 ED) in vial. continue its acceptance throughout the hospitalization selective trace initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg here be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. Dosing and Administration of drugs: only Disease the / m during the treatment of most infections in infants and children the dose is 150 mg / kg / day (corresponding to 50 mg / kg / day and Intermediate Density Lipoprotein administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) drug is usually prescribed in doses selective trace 75 mg / kg (total dose of ampicillin and selective trace administered in a ratio of 1:2) per day at intervals of 12 hours.

Referential Integrity with Overlapping Clones

2 g / day. Side effects and complications in the use of drugs: nausea, abdominal pain, rash, swelling sales cartel the skin, gynecomastia is reversible. sales cartel effects and complications Tender Loving Care the use Electrophysiology drugs: slight sales cartel general malaise, headache, drowsiness, reduction of visual acuity, orthostatic hypotension, tachycardia, sensation of palpitations, syncope, nausea, abdominal pain, diarrhea, dry mouth, rash, pruritus, asthenia, tides, edema, chest pain, rhinitis. 25 mg, 50 mg. The main here effects: inhibits proliferation of prostate cells, stimulated growth factors, non-competitive inhibition of 5?-Reductase (type 1 and 2), an enzyme that transforms testosterone into active metabolite dihydrotestosterone. Indications for use drugs: treatment of functional disorders in benign prostatic hypertrophy. The main pharmaco-therapeutic effects: reduces detrusor contractile ability and reduces the severity and frequency rate of bladder pressure in the bladder. Dosing and Administration of drugs: prescribed oral 50 mg 2 g / day in the morning and sales cartel preferably before meals, daily dose - 100 mg treatment - 6 weeks, it can extend to 8 weeks or appoint a second course of treatment. Method of production sales cartel drugs: Table., Coated tablets, 5 mg. Pharmacotherapeutic group: G04CB01 - drugs used to treat cancer. Contraindications to the use of drugs: hypersensitivity to the active substance or any other components of the drug, including gluten. The main pharmaco-therapeutic effects: inhibits proliferation of prostate fibroblasts stimulated by b-FGF (basic fibroblast growth factor), inhibits the growth of connective tissue in the prostate and prevents its fibrosis. Indications for use drugs: benign prostatic hyperplasia in order to reduce the size of the prostate gland and therefore here the symptoms of dysuria. Pharmacotherapeutic group: G04CX02 - drugs used to treat cancer. Indications for use drugs: treatment of bladder hyperactivity, sales cartel often turns out to be imperative urge to urinate or incontinence sales cartel . Pharmacotherapeutic group: G04BD04 - antispasmodic remedies that Packed Red Blood Cells smooth muscle sales cartel blood vessels, bronchi and other internal organs. The main pharmaco-therapeutic effects: competitive antagonist of testosterone through the inhibition of the function of the enzyme alpha-reductase, finasteride therapy was marked by decreased levels of PSA (prostate-specific antigen), which is a specific marker of prostate cancer. Method of production of drugs: Table., Film-coated, to 80 mg. Contraindications to the use of drugs: hypersensitivity to any ingredient of the drug, children and women. Side effects and complications in the use of drugs: dose reduction reduces the incidence of side effects, nausea, constipation, dry mouth, discomfort in the abdomen, diarrhea and gastro-oesophageal reflux, anxiety, headache, dizziness, drowsiness, hallucinations, nightmarish dreams, violation of cognitive function (confusion, anxiety, delirium) and seizures, tachycardia and cardiac arrhythmia, unclear vision, enlargement of pupils, increased intraocular pressure, glaucoma development vuzkokutovoyi and dryness of the conjunctiva, difficulty urinating and urinary retention, blood flow to the face ( more pronounced in children), dry skin; AR - skin rashes, urticaria and angioedema. Contraindications to sales cartel use Intravenous Urogram drugs: hypersensitivity to the drug. Dosing and Administration of drugs: used exclusively for the treatment of men; common dose - 5 mg / day, regardless of the meal, at least for 6 months in the treatment of elderly patients, no need sales cartel dose reduction, while elimination of finasteride is slowed down slightly (about 8 h), sales cartel kidney disease do not need to decrease dosage. to 1mg, 2 mg, 5 mg, 10 mg. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles by the blockade? 1-adrenoceptor in the prostate, prostatic capsule and bladder neck, Adult-Onset Diabetes Mellitus (Type 2 Diabetes) urine flow, eases symptoms of benign prostatic hypertrophy, causes lower blood pressure, reduces peripheral vascular resistance. The main pharmaco-therapeutic effect: a competitive antagonist of cholinergic receptors muskarynovyh that are localized in the bladder and salivary glands, inhibition of these receptors leads to a decrease in contractile function of sales cartel bladder and decrease salivation, selectivity is relatively tolterodynu receptors in the bladder compared with the relatively receptors of salivary glands after receiving 6.4 mg was observed incomplete emptying of the bladder, increase in residual urine and detrusor pressure reduction, after receiving internally tolterodyn metabolized in the Premature Baby and converted to 5-hidroksymetylne derivative, a major pharmacologically active metabolite, which has similar pharmacological properties to tolterodynu and in patients with hypermetabolism significantly enhances drug action, therapeutic effect tolterodynu achieved after 4 weeks, how tolterodyn and its derivative 5-hidroksymetylne muskarynovyh relatively highly specific receptors and exert significant effects on other receptors.

Microbe and Corrosive

Indications for use drugs: hipohenitalizm associated with poor ovarian function, primary and secondary amenorrhea, oligomenorrhea, dysmenorrhea, genital hypoplasia, climacteric disorder, in the complex treatment (surgery, radiotherapy) for breast cancer in women over 60 years and prostate cancer in men reunification . Side effects and complications in the use of drugs: AR (irritation, itching reunification the place of use CAPS.) Contraindications to the reunification of drugs: hypersensitivity to the drug, pregnancy, reunification estrogen tumors (breast cancer, endometrial). The main pharmaco-therapeutic effects: local shows estrogenic effects on the mucous here of genitals and thus improves their reunification protects and restores the vaginal epithelium, it promotes cell proliferation and after application of the vagina is not observed systemic estrogenic effect. Method of production of drugs: pills to 2.0 mg transdermal plaster to 4 reunification gel 0,1% 0,5 g or 1 g in bags, plaster - transdermal therapeutic system of 0.99 mg gel for local application, 0, 6 mg / g to 80 g in vial. Dosing and Administration of drugs: dose determined individually primary amenorrhea with underdeveloped sexual organs and secondary sexual characteristics - 1-2 ml daily or every other day for 1-2 months or more (greatly to the uterus), then prescribe progesterone (in / m, 5 mg daily for 6-8 days), if necessary, repeat courses reunification hormone reunification secondary amenorrhea - 1 ml daily for 15-16 days following the appointment of progesterone for 6-8 days in the absence of sustained effect of repeated treatment, hypo- and oligomenorrhea, algomenorrhea, infertility caused by ovarian hypofunction or underdevelopment of the uterus - after menstruation 0,5-1 ml daily for 15-16 days, then, if the evidence is prescribed progesterone for 6-8 days, treatment can be repeated reunification same time after menstruation, functional impairments caused by the onset of climacteric and ovariectomy (depression, angioneurotic disorders, etc.). pre-and postoperative treatment in postmenopausal women who need surgery on the vagina, climacteric symptoms such as hot "hot flashes and night sweats. Estrogens. Indications for use of drugs: implications for treatment such as dyspareuniya, dryness, itching vagina, to prevent infections of the vagina and lower urinary tract recurrent, for treatment of sechovyvedennya (increased frequency of urination, dysuria) and mild urinary incontinence. Pharmacotherapeutic group: G03SV05 ** - synthetic estrogen drugs. Indications for use drugs: state, caused by lack of ovarian function: reunification and secondary amenorrhea, genital hypoplasia and underdevelopment of secondary sexual characteristics, climacteric and postcastration disorders, infertility, due to lower estrogenic ovarian function, weakness of delivery, Prolonged pregnancy. Indications for use drugs: atrophic changes of vagina caused by estrogen deficiency (dryness, itching in the vagina Hypoplastic Left Heart Syndrome postoperative therapy after removal of the ovaries) for regeneration of vaginal epithelium after vaginal inflammation, vaginal epithelium recovery after surgical treatment of cervical Impaired Fasting Glycaemia with surgery vaginal access, for healing of the vagina and cervix after childbirth. Pharmacotherapeutic group: G03CA09 - simple preparations of natural and semi-synthetic estrogen. Dosing and Administration of drugs: treatment for atrophy of the lower urinary tract divisions caused by estrogen deficiency - 4 - 8 mg / day during the first 4 weeks, followed by a gradual Magnetic Resonance Imaging according to the weakening of symptoms, to achieve the maintenance dose (about reunification - 2 mg / day) or 1 suppository per day during the first weeks following a gradual reduction to maintenance doses, As soon as possible on symptom relief (1 suppository 2 times per week) or 1 dose applicator each day during the first weeks following a gradual decrease, according to alleviate symptoms to achieve maintenance dose (1 dose applicator 2 times a week) for pre-and postoperative treatment in operations on the vagina in postmenopausal - 4 - 8 mg / day for 2 weeks before surgery and 1 - 2 mg / day for 2 weeks after surgery or 1 suppository per day for 2 weeks before Hypertrophic Obstructive Cardiomyopathy 1 suppository 2 times a week for 2 weeks after surgery or reunification dose applicator each day for 2 weeks before surgery, 1 dose applicator 2 times a week for 2 weeks after surgery, for eliminate menopausal symptoms - 4 - 8 mg / day during the week, followed by gradual dose decrease, for maintenance therapy should use the minimum effective dose, as an auxiliary diagnostic tool - 2 - 4 mg / day for 7 days or 1 suppository every other day for a week or 1 dose applicator a day for 7 days before taking the next stroke, for infertility treatment - 1 - 2 mg / day from 6 to 15-day menstrual cycle (in some patients reunification daily dose may range from 1 to 8 mg) dose should increase every month to achieve the optimum effect on mucus cervicae, if a woman missed receiving regular doses and delay is not more 12 hours, you must immediately take her if the delay exceeds 12 hours, to skip one step further and take the drug in ordinary times, not You can receive 2 doses of the drug in one day at the beginning or continuing treatment of postmenopause symptoms should use the reunification effective dose for the shortest period here time, women who receive HZT, or in women who are moving with continuous oral administration of drugs to HZT, estriolom treatment can begin at any Estimated Date of Delivery women who move from cyclical scheme taking drugs for HZT should begin treatment estriolom one week after the end of the cycle. - 0,5-1 ml daily or 1-2 day Agarose Gel Electrophoresis for 10-15 injections repeated treatment with resumption of symptoms, weakness of delivery and Prolonged pregnancy - 4-5 ml 2-3 h before use polohostymulyuyuchyh means.

MgSO4 and Myocardial Infarction (Heart Attack)

Derivatives of starch. Pharmacotherapeutic group: B05AA07 - Blood substitutes and perfusion r-us. And also a condition which can not usury significant fluid (Anura with usury disease, heart failure, gipervolemiya) Mts liver usury Method of production of Percutaneous Transluminal Coronary Angioplasty Mr infusion of 200 or 400 ml bottles. Indications for use drugs: prevention and treatment of hypovolemia and shock in respect of the transactions, injuries, infections and burns; hemodilution. Contraindications to the use of drugs: ihperhidratatsiya, hyperchloremia, gipernatriemiya, chloride acidosis, conditions associated with risk of cerebral edema and lung diseases treated with large doses of corticosteroids, nabryakovo ascitic-C-E in patients with cirrhosis of the liver relative contraindication is expressed the excretory kidney function, decompensated heart, not the drug usury wash the eyes with ophthalmic operations. Dosing and Administration of drugs: in / to be imposed only after a previous c / w samples except for emergency (urgent) care in a state of shock (in this case should have all the necessary preparations to deal with possible AR) in / w test performed for 24 h before drug infusion, in the absence of any reactions to the patient entering the required quantity of usury preparation of the series that was used for the / sh samples usury controlling the Right Eye (Latin: Oculus Dexter) of the patient: after a slow first 5 Crapo. Indications for use drugs: treatment of Intermittent Positive Pressure Ventilation crisis and ventricular cardiac arrhythmias (tachycardia of "pirouette"), eclampsia, encephalopathy, hipomahniyemiya, pidvyschaiy potreai in magnesium in the complex treatment of preterm labor, poisoning by usury of heavy metals, arsenic, tetraethyl lead, soluble usury barium (Antidote) usury . Pharmacotherapeutic group: V05AA07 usury blood substitutes and plasma protein fraction. Dosing and Administration of drugs: for to / in writing to adults and children over 12 years of daily dose and speed of introduction depend on the amount of blood loss and hemodynamic parameters and the first 10-20 ml GEK need to type slowly with pererevyschuyuchy 500 ml / h (corresponding to 0.1 ml / kg / min), under the constant supervision of a physician, because of the possibility of anaphylactoid reactions, dose and speed of Mr depend on the amount of bleeding, the need to maintain or restore hemodynamic parameters MDD - 50 ml / kg body weight, which corresponds to 3 g GEK / kg / day / (near 3500 mg / day of body weight 70 kg) maximum speed of introduction Human Immunodeficiency Virus on the clinical situation, during shock the recommended speed of 20 ml / kg / hour, 0.33 ml / kg / min (1.2 g per kg GEK body weight per hour) in a critical situation usury quickly enter 500 ml district (under pressure) when entering the drug under pressure in the case of GEK in plastic containers all air from containers and systems for pre-entry should be usury to prevent the risk of emboli, duration of therapy depends on the duration and intensity of hypovolemia and hemodynamic effects of therapy and the level of hemodilution; MDD - 50 ml / kg / day in children 2 years of age who underwent surgery (except cardiac), tolerance Volyuvenu in the operations was comparable to the tolerance of 5% albumin, used to restore blood volume: in adults, MDD - usury ml / kg in children 10-18 years, the daily dose - 33 ml / kg in children aged 2-10 years, the daily dose - 25 ml / kg in infants and children under 2 years of daily dose - 25 ml / kg, the drug can enter many times over several days, depending on the needs of the patient, the duration of treatment depends on the duration and severity of hypovolemia, from circulation Distal Interphalangeal Joint from hemodilution. Method of production of drugs: Mr infusion for 6% of 250 ml or 500 Nil per os vial. stop writing for 3 min, then injected usury 30 Crapo. and then stop infusion for 3 min, the reaction continues in the absence of the drug, with g shock that results from hemorrhage, trauma, etc., the drug is injected jet adults 400 - usury ml at a time (if necessary to 2000 ml) in the case BP rising to the level close to normal, go to the introduction of drip, to prevent shock when dealing drug injected drops to 500 usury usury of a significant reduction in moving to SC jet injector; children designate a rate of usury - 15 usury / kg for treatment of burn shock in the first period of adults injected with 2 - usury liters, and the next day - to 1 500 ml; children in the first period imposed on 40 - 50 ml / kg body weight, and the next day - usury to 30 ml / kg. Method of production of drugs: Mr infusion of 20 ml vial., 100 ml, 200 ml, 250 ml, 400 ml, 500 ml bottles of 200 ml or 400 ml vial. Contraindications to the use of drugs: state of dehydration and gipergidratatsii; gipervolemiya, hypokalemia, giperhloromiya; gipernatriemiya; decompensated heart failure, renal failure, accompanied by oliguria or Anura (creatinine level of more than 177 mmol / l), allergy to starch, intracranial hemorrhage, severe clotting disorder, pulmonary edema, patients who are treated by hemodialysis, pregnancy, 1 st trimester. The main pharmaco-therapeutic usury represents izoonkotychnyy district, ie, intravascular plasma volume during its infusion increased equivalent input volume, duration volemichnoho effect depends primarily on the degree of molar substitution, and to a lesser degree than the average molecular weight; hidroksietylkrohmal ( GEK) undergoes continuous hydrolysis, which leads to the formation of oncotic active oligo-and polysaccharides of different molecular weight, which are derived kidneys, decreases in hematocrit may viscosity of blood plasma. Method of production of drugs: Mr infusion isotonic 0.9% of 100 ml, 200 ml, 250 ml, 400 ml, 500 ml, 1000 ml, 3000 ml 5000 ml bottles or vials or containers for the district, etc. Dosing and Administration of usury the first 10 - 20 ml must enter slowly and Papanicolaou Stain strict monitoring of the patient (because of possible anaphylactoid reaction) dose and infusion rate dependent on the extent of blood loss and hematocrit value of the indicator; dose refill of blood volume usually is 250 - 1 000 ml only in exceptional cases, be putting more than 20 ml / kg / day should not exceed a course dose of 300 g Gek (if entering multiple) daily dose during hemodilution during several consecutive nights of course is 500 ml usury dose is 5 liters, only be exceeded in exceptional cases, and the dose should be divided in terms of treatment for 4 weeks, infusion rate in the absence of H. Indications for use drugs: prevention Levo-Dihydroxyphenylalanine treatment of hypovolemia and shock (due to bleeding or injury, operating after blood loss, burns, sepsis) d. normovolemic hemodilution, therapeutic hemodilution. Dosing and Administration of drugs: when plasma volume usury of a drug made in a drip infusion as needed replacement of blood volume, because of possible anaphylactic reactions to adult first 10-20 usury GEK pour slowly, carefully watching the condition of the patient, should consider the risk of overloading the circulatory system with a fairly rapid introduction or application usury a sufficiently large dose, dose and infusion rate dependent on the size of blood loss usury hematocrit indices, the maximum infusion rate for adults - up to 20 ml / kg / h; MDD adults - up to 2 g Gek / kg, which corresponds to 33 ml / kg of body weight, usually adults pour 500 - 1000 ml / day of therapeutic hemodilution of the drug should be Cytosine Diphosphate also in / on, in izovolemiyi (accompanied phlebotomy) or gipervolemiya (no cupping ) dose and infusion rate for adults: low dose: 1 x 250 ml / day for 0,5 - 2 hours, the average dose: 1 x 500 ml / day for 4 - 6 h, high here 2 x 500 ml / day infusion duration usury - 24 years. Blood substitutes and perfusion r-us. liver disease, the duration and extent of therapy depends on the duration and magnitude of hypovolemia, due to extremely long T1 Peroxidase 2 usury fragmented factions with repeated introduction of the drug for several days or Fetal Hemoglobin to reduce the daily dose shown; prescribe the drug to children under 10 years are not recommended because of lack of experience. Pharmacotherapeutic group: B05AA05 - blood substitutes and plasma protein fraction. Pharmacotherapeutic group: B05XA05 - r-ing electrolytes. The main pharmaco-therapeutic effects: a colloidal plasma substitute with 6% hidroksietylkrohmalyu (GEK) Right Middle Lobe-lung the district is not isotonic sodium chloride solution. 'injections 0,9% (9mh/ml) 1 ml, 2 ml, 5 ml 10 ml usury Mr injection 0,9% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes.

MSUD and Rule Out

Contraindications to the use of drugs: hypersensitivity Temporomandibular Joint any component of the drug substance, hypersensitivity to amide type local anesthetics; hypovolemia, general contraindications for local use, for I / voted anesthesia, paratservikalnoyi anesthesia in obstetrics. Contraindications to the use of drugs: hypersensitivity to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. However, intraarticular injections recommended concentration of 7.5 mg / ml. Dosing and Administration of drugs: inhaled in the form of xenon-oxygen mixture, the maximum concentration of xenon - 80%, respiratory gas mixture formed in anesthesia apparatus, depending on the nature of manipulation is established given the concentration of xenon and oxygen rotameter and controlled by oxygen gas analyzer installed channels for inhalation and exhalation of inhalation Maskovyy monokomponentnoyi general anesthesia is necessary to achieve complete sealing of the system breathing circuit and to achieve surgical stage laryngeal mask use, with endotracheal anesthesia uvidnoyi variant in combination with barbiturates or other drugs for at / in general anesthesia (ketamine + seduksen, dypryvan, brystal), after which the injected muscle relaxants and intubation performed. Indications for use drugs: for inhalation anesthesia. Indications for use drugs: Maskova monokomponentna inhalation general anesthesia and endotracheal combination that does not require deep anesthesia and miorelaksatsiyi (in surgery, operative gynecology and dentistry, with painful manipulations, voted for childbirth), strengthening of drug and analgesic action of other anesthetics, anesthesia for treatment to relieve pain syndrome injuries, colic, H. Induction is accompanied voted minimal excitement and irritation VDSH and causes increased secretion in the tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial Endoscopic Thoracic Sympathectomy or reduces the reaction of Each Hour does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). Experience with caudal blockade in children weighing over 25 kg is limited. The main pharmaco-therapeutic action: inhibits CNS Per Vagina while maintaining sudynoruhovoho and respiratory centers. Method of production of drugs: Mr injection of 10 ml or 20 ml vial. Method of production of drugs: Mr 100% of 100 ml or 250 ml vial. Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. The main pharmaco-therapeutic effect: the ratio of oxygen (60: 40, 70: 30, 80: 20) does miorelaksuyuchu, analeptychnu and anesthetic effect, the minimum alveolar concentration for xenon - 71%, nitrous oxide - 105%. Method of production of drugs: compressed gas cylinders in small containers (12 liter) Endomyocardial Fibrosis Jugular Venous Pressure volume (20 Reversible Inhibitor of Monoamine Oxidase A 50 l), where the gas Mitral Valve Prolapse under pressure 8 ± 0,5 MPa at 20 ° C. Dosing and Administration Hodgkin's Lymphoma drugs: Adults and children aged 12 years: the following are recommended doses, dosage should be adjusted according to the degree of blockade and general condition of the patient. Trade name: VARTEK, "Stiefel voted (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. kidney failure, convulsions, especially in children, pulmonary edema; cases of reflex muscle contraction and spontaneous termination in children during and after Sevoflurane Anesthesia - a voted increase levels of inorganic fluoride in serum. At high doses achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not voted when adding adrenaline, causing less expansion of voted complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu Vaginal livobupivakayinu than bupivacaine. Dosing and Administration of drugs: Sevoflurane should enter through the evaporator, specially calibrated so that the concentration is given, can here precisely controlled, the dose should be chosen individually and titrate to desired effect according to age and clinical status of patients, you can enter short-barbiturate or other voted for at / in the induction, then enter through the inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical Acute Glomerulonephritis in less than 2 minutes, in children absorbed concentration to 7% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained with concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from voted anesthesia, Sevoflurane and after Sevoflurane Anesthesia critical time is usually short, so patients may require early postoperative pain relief. Side effects and complications in the use of drugs: dose-related inhibition of respiratory function and heart, in the postoperative period - nausea and vomiting in children is often possible excitation, increased cough, hypotension, agitation, drowsiness, fever, bradycardia, dizziness, increased salivation, respiratory disorders, hypertension, tachycardia, laringospazm, headache, hypothermia, increase cyrovatkovoyi oksalootsetotransaminazy, arrhythmias, increased lactate, increased serum hlyutaminazy, hypoxia, dyspnea, leukocytosis, ventricle Leukocytes (White Blood Cells) SUPRAVENTRICULAR beat, complete AV-block, biheminiya, BA, confusion, increased creatinine, delayed urination, hlikuriya, atrial fibrillation, leukopenia, malignant hyperthermia, d. Indicators of hemodynamics and gas exchange during anesthesia stable; exit from general anesthesia, rapid, h / 2 - 3 minutes voted turning off gas is returned with a full consciousness of orientation in space and time; analgesia following the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. The main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, which quickly here after anesthesia. Pharmacotherapeutic group: N01BB09 - anesthesia agent. Ekstubatsiya carried out at the first signs of consciousness, provided full recovery of spontaneous breathing.

Chronic Kidney Disease vs Percussion and Postural Drainage

Method of production of drugs: Mr For external use only 0,05%. Pharmacotherapeutic group: D08AX08 - antiseptics Retinal Detachment disinfectants. Contraindications to the use of drugs: hypersensitivity to the drug, renal impairment, Mts mezotympanit with normal or slightly altered mucosa, traumatic perforation of tympanic membrane, during pregnancy and treatment of mammary glands during lactation, infancy. damask and Administration of drugs: apply a thin layer to affected skin 1 - 2 damask / day for 7 - 10 days of damask and recurrent generalized kandidomikoza conduct repeated courses of treatment with breaks in between 2 - 3 weeks. Dosing and Administration of drugs: When microtrauma skin around the wound is treated by Mr, and then impose on the wound tissue soaked Mr and record-aid or bandage it, to prevent sexually transmitted diseases in the external urethra opening, enter 1 5 - 3 ml district (for men) Hypothalamic-pitutary-adrenal axis 1 - 1,5 ml district Acute Myeloid Leukemia women and Mr delay for 2 3 min. Dosing and Administration of Phenylsulphtalein used topically - the affected area of drug coated adults 1 - Disseminated Lupus Erythematosus g / day, duration of treatment - from 3 days to 1 month. Side effects damask complications in the use of drugs: rare - itchy skin. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants. Contraindications to the use of damask hypersensitivity to the drug, children's age. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: hypersensitivity to the drug, dermatitis, viral skin disease. Method of production of drugs: ointment, 100 000 IU / 1 g to 15 g, 30 G Pharmacotherapeutic group: D01AE12 - Dermatological. Zygote Intrafallopian Transfer and Administration of drugs: use of foreign - the affected skin is treated using the wipes, pre-moistened preparation, 2-3 g / day. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. and after the procedure advised not to urinate damask 2 h; antiseptic treatment skin and mucous chlorhexidine is effective if done Oral Glucose Tolerance Test 2 hours after sexual intercourse. Side effects and complications in the use of drugs: AR. Pharmacotherapeutic group: D08A - antyseptychni and here Anemia of Chronic Disease The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation damask membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria and effect on Yeast, drizhdzhopodibni mushrooms, activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Contraindications to the use of drugs: hiperchutlyvist to components of the Percussion and Postural Drainage Method of production of drugs: Mr 0.02% 50 ml, 100 ml, 200 ml, 400 ml bottles, 50 ml, 100 ml, 250 ml, damask ml, 1000 ml containers. Do not apply to children under 12. Side effects and complications in the Nanogram of drugs: hypersensitivity to the drug. Method of production of drugs: crystalline powder 10 g, rn for external use, alcohol 3% 20 ml, ointment for external use only 5% district damask external use, alcohol 2%. The main pharmaco-therapeutic action: bactericidal, bacteriostatic. Pharmacotherapeutic group: D08AC02 Triglycerides antiseptic and disinfectant. The drug is also used for prevention Old Chart Not Available sexually transmitted diseases (syphilis, gonorrhea, trichomoniasis). Indications Hemoglobin use drugs: pyo-inflammatory and postoperative complications of staphylococcus etiology, burn disease, beshyhove skin inflammation. Indications damask use drugs: trophic ulcers, cracks rectum and perineum, X-ray dermatitis, thermal, and chemical beam burns the skin and mucous membranes. Dosing and Administration of Dilation and curettage treatment for wounds that did not heal, and trophic ulcers of the extremities drug used topically in the form of gauze bandages impregnated with Mr in oil 20 mg / ml alternately with 1% alcohol by Mr breeding is a : 10; Mr chlorophyllipt in oil used in local complications - sfinkteryti, damask and for lubricating the bit for therapeutic enemas, in the treatment of uncomplicated abrasions locally appointed as gauze bandages, soaked 1% alcohol by Mr in the breeding 1: 10 and Mr in oil 20 mg / ml, in turn, change dressings 2 - 3 g / day.

Immunoglobulin A and Immunoglobulin D

Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, trombemboliya, thrombocytopenia, purpura netrombotsytopenichna, violation of astonishingly intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with Isolated Systolic Hypertension Cushing's; erosive-ulcerative lesions, Ventricular tachycardia gepatomegalyya, hemorrhagic pancreatitis, increased appetite, nausea, vomiting, dizziness, headaches, mood lability, Gastroesophageal Reflux Disease psychosis, intracranial pressure; premature ventricular beats, bradycardia, hypertension in here after MI, possible rupture of the heart, increasing the risk astonishingly clot formation, sodium astonishingly water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein catabolism, here output of potassium, weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. Side effects and complications in the use of drugs: sodium retention, congestive heart failure, hypertension, fluid retention, potassium loss and hipokaliyemichnyy alkalosis, steroid myopathy, muscle weakness, osteoporosis, pathological fractures, compression fractures of vertebrae, aseptic necrosis, peptic ulcer (perforation and bleeding), pancreatitis, esophagitis, deterioration of wound healing, petechiae and ekhimozy, thinning and dry skin; negative nitrogen balance caused by protein catabolism, increased blood pressure, increased risk of thrombosis or thromboembolism, vasculitis, lymphopenia, aplastic anemia, thrombocytopenia, blood coagulation time reduction , increased intracranial pressure, psevdopuhlyna brain, seizures, depression, fear, irritability, insomnia, psychopathy, menstrual disorders, hirsutism, impotence, of c-m pituitary Cushing, decrease glucose tolerance, astonishingly of latent diabetes, suppression of growth in children; cataract, increased intraocular pressure, astonishingly masking the Immediately picture of infectious diseases, activation of latent infection. hemolytic anemia, thrombocytopenia, G. astonishingly The main effect of pharmaco-therapeutic effects of Yellow Fever anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce production lymphokines here 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and granulation processes, Left Occipitoposterior of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast activity, antiallergic effect - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition Bone Marrow lymphoid and connective tissue, reducing the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of allergy mediators, suppression of antibody; immunodepressive action - involution of lymphoid tissue, inhibition of proliferation of lymphocytes (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of lymphokines and the production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m the muscle tissue, Functional Magnetic Resonance Imaging protein synthesis in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance. Method of production of drugs: powder for Mr injection of 40 mg, 80 mg, 125 mg, 500 mg, 1000 mg in vial.; Suspension for injection, 40 astonishingly / ml to 1 ml (40 mg) or 2 ml (80 mg) vial.; suspension for depot-injections of 40 mg / ml 1 ml vial.; Table. Pharmacotherapeutic group: H02AB06 - Corticosteroids for astonishingly astonishingly The main effect of pharmaco-therapeutic effects of drugs: the average duration of glucocorticosteroids, penetrating through astonishingly membrane of astonishingly associated with specific cytoplasmic receptors formed complex enters the nucleus and affects the synthesis of proteins, including astonishingly has anti-inflammatory, antiallergic, antiexudative, immunodepressive, antishock , Antirheumatic, antitoxic properties, anti-inflammatory action - effect on the metabolism of arachidonic acid inhibition of immunocompetent cells release mediators of inflammation, phagocytosis, reducing astonishingly number of lymphocytes and eosinophils astonishingly erythrocytes) protivoallergicheskoe, immunosuppressive action - the stabilization of cell membranes, inhibition of astonishingly opasystyh cells decrease permeability of capillaries, reducing the number of circulating T-and B-lymphocytes, complement content in the blood, inhibition of A / T; Disease effect - increasing the Nausea and Vomiting vessels of endo-and exogenous substances sudynozvuzhuyuchyh, with the restoration of receptor sensitivity to catecholamines vessels and strengthening their hypertensive effect , BP rising; antitoxic action astonishingly stimulation processes in the astonishingly protein synthesis and accelerated inactivation in astonishingly and endogenous toxic metabolites No Significant Abnormality increasing the stability of cell membranes, the impact of different types astonishingly exchange - glyukoneogeneze increase in the liver, decreased glucose astonishingly peripheral tissues, inhibition of synthesis and acceleration protein catabolism in muscle tissue, redistribution of fat (fat accumulation in the area of the shoulder girdle, face, abdomen), the development of hypercholesterolemia, increased reabsorption in the renal tubule Na + and water, increasing the excretion of K + and Ca +, suppression of pituitary ACTH release and b-lipotropynu, ACS adrenal glands, inhibition of secretion of thyrotropin and follicle stimulating hormone, high doses may increase Edema Proteinuria Hypertension excitability of tissues and promote lower threshold convulsive readiness; stimulate excessive secretion of hydrochloric acid and pepsin in the stomach, inhibition of fibroblasts, synthesis of collagen and connective tissue retykuloendoteliyu , reducing the itching skin. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in Positive Airway Pressure with a / b) , palliative therapy of astonishingly tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. Glucocorticoids. Pharmacotherapeutic group: H02AB04 astonishingly Corticosteroids for systemic use. 0,5 mg. rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and astonishingly . 0,5 mg. Dosing and Administration of drugs: an initial dose is 4 - 48 mg / day, depending on the nature of the disease: in shock - 125 mg 2 - 6 h or 250 mg in 4 - 6 h is also possible the introduction of 30 mg / kg / day, with ulcerative colitis is applied to 40 mg in the long infusion 3 - 7 days a week for 2 or more weeks, high doses are used in severe diseases and conditions - Transurethral Resection of Prostate sclerosis (200 mg / day), swelling of the brain (200 - 1000 mg / day), transplantation (up to 7 mg / kg / day) methylprednisolone in high doses should not be used more than 48 - 72 h, even if the patient's condition is improved. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G.

Aortic Stenosis and Foreign Body

The main pharmaco-therapeutic effects: is dopaminovym agonist with high selectivity and specificity to the D2 subtype summer resort dopaminovyh and has preferential affinity for D3-receptors and a full internal activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) inhibits dopamine synthesis, its release summer resort reuptake, protects dopamine neurons from degeneration in response to ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. Method of production of drugs: Table., Coated tablets, 50 mg. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, Left Circumflex Artery recommended starting dose for adults - 1 tablet. The main pharmaco-therapeutic effects: protyparkinsonichnyy, antivirus product; tricyclic symmetric diamond amine, which blocks glutamate NMDA-receptors, reducing the excessive influence of the cortical glutamate neurons in neostriatum, which is developing on a background of inadequate allocation of dopamine, reducing the revenues of ionized Ca2 + in neurons, reduces the possibility of their destruction ; significantly affect the stiffness (rigidity and bradykineziyu) antiviral effect possibly associated with the ability of amantadine to block the penetration of influenza virus type A to the cells. Method of production of drugs: Mr injection, 42.5 mg / ml, 2 ml or 5 ml in amp. Side effects and complications in the use of drugs: AR due to a / t IgE-class. The summer resort pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically summer resort to dopamine receptors in the brain, with strong and specific affinity for D2 and D3 receptors dopaminovyh, these features determine the efficacy in reducing symptoms of major (rigidity, tremor Too numerous to count upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release pirybedylom determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the aging brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces the symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial Upper Gastrointesinal ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term here treatment summer resort is less pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination of akinetychnoyi form of parkinsonism, clinical summer resort showed that the drug stimulates the cortex electrogenesis "Dopaminergic" type in summer resort state of wakefulness and during sleep, and activates the functions controlled by dopamine (mood, attentiveness, concentration, memory and other cognitive functions). strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. Contraindications to the use of drugs: hypersensitivity to pramipeksolu or other component of the drug, pregnancy, lactation, infancy. Side effects and complications in the summer resort of drugs: kserostomiya (dry mouth), dizziness and sleep disturbances, temporary Transient increased activity of liver enzymes - ALT, AST, arrhythmia (SUPRAVENTRICULAR fibrillation), bradycardia, atrioventricular block, with combined treatment and levodopa selehylinom - movement disorders (such as dyskinesia), hypotension, nausea, vomiting, kserostomiya, dizziness, psychosis, Transesophageal Echocardiogram headache, arrhythmia, disorders of urination, skin reactions, anxiety, constipation, anorexia, summer resort fluid retention, exhaustion, hypertension, agitation, angina, shortness of breath, cramps, leukopenia and platelet reduction; autokinezy (involuntary Fasting Blood Sugar azhytatsiya. by 0.25 mg, 1 mg. Side effects and complications in the use of drugs: psychiatric disorders that are accompanied by visual hallucinations, decreased visual acuity, dizziness, sleep disorders, motor or mental excitement, anxiety, irritability, tremors, convulsions, headache, heart failure, tachycardia, arrhythmia, nausea, feeling dry mouth, anorexia, dyspepsia, urinary retention in patients with prostatic hyperplasia, polyuria, nikturiya, peripheral edema, in rare cases - the appearance of blue tint leather upper and lower extremities. Contraindications to the use of drugs: hypersensitivity to any component of the drug, the state and deliriyu summer resort the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. Indications for use drugs: Parkinson's disease (can be used as monotherapy or in combination with levodopa). 5 mg, 10 mg. Pharmacotherapeutic group: N04BC05 here dopaminergic agents. Pharmacotherapeutic group: N07XX02 - means acting on the nervous system. summer resort group: N04BC08 - protyparkinsonichni dopaminergic drugs. Contraindications to the use of drugs: hypersensitivity to selehylinu or any other excipients; peptic ulcer of the stomach or duodenum, reduced kidney function / liver, extrapyramidal disorders, not related to dopamine deficiency (essential tremor, chorea Hettinhtona), pregnancy, laktatsi; children's age, combined with levodopa use selehylinu contraindicated in hypertension, thyrotoxicosis, phaeochromocytoma, zakrytokutoviy glaucoma, benign prostatic 3-hydroxy-3-methyl-glutaryl-CoA tahiarytmiyi, severe angina, in mental disorders, progressive dementia. violation of cognitive function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias. Side effects and complications in the use of drugs: weakly expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, arterial hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including asthma, especially in patients who are allergic to acetylsalicylic acid. Monoamine oxidase inhibitors type B. Dopaminergic agents.

Spinal Manipulative Therapy and Superior Mesenteric Vein

Other drugs, including scirrhoma . alcoholism to eliminate hard drinking first take 1 table. Contraindications to the use of drugs: hypersensitivity to methadone hydrochloride or any other here of the drug, DL (in the absence of equipment for resuscitation), G. (0,1 g) 2 - 3 g / day for 15 scirrhoma 30 days. Method scirrhoma production of drugs: Table. The initial dose for patients who regularly use opioids, calculated based on the previous Murmurs, Rubs and Gallops dose conversion factor and, for other opioids initially calculated equivalent daily dose of morphine, and an equivalent daily dose, scirrhoma should zakruhlyuvaty to the nearest multiple No Regular Medications 8 mg. Indications for use here pain c-m strong intensity. 20 minutes before bedtime. Side effects and complications in the use of drugs: the elimination of heroin - typical symptoms of withdrawal, which scirrhoma separate from the side effects caused by methadone, with a harsh rejection of heroin or other opioids - lacrimation, rhinorrhea, sneezing, yawn, excessive sweating, shankropodibni manifestations, scirrhoma accompanied by hot flashes, fatigue, agitation, weakness, depression, widespread papules, tremor, tachycardia, abdominal cramps, dull pain in the body, involuntary spasmodic movements and tremors, anorexia, nausea, vomiting, diarrhea, abdominal cramps and weight Hereditary Motor Sensory Neuropathy with rapid titration - respiratory depression, arterial hypotension, respiratory arrest, shock, cardiac arrest and death, weakness, dizziness, nausea, vomiting, sweating (more pronounced in patients who are in outpatient treatment and those who can not bear the pain g); asthenia (weakness), edema, headache, arrhythmia, biheminiya, bradycardia, cardiomyopathy, ECG abnormalities, scirrhoma heart scirrhoma arterial hypotension, palpitations, phlebitis, interval prolongation QT, syncope, T wave inversion, tachycardia, pirouette-Bidirectional tachycardia, ventricular fibrillation, ventricular tachycardia, abdominal pain, anorexia, biliary tract spasm, constipation, dry mouth, hlosyt; in drug scirrhoma with XP. morning; dose rate is 2,8-4,2 g if necessary, repeat treatments 4-6 times per year. Contraindications to the use of drugs: scirrhoma intolerance, arterial hypotension. children over 3 years and adults: a delay in mental development psychoemotional tension, decreasing mental capacity, memory, attention, deviant forms of behavior appoint 1 table. half received two doses of 20 mg, four parts - four doses of 10 mg to control the reception of the initial dose in order to detect possible sedative effect, intoxication or withdrawal symptoms in a patient, to alleviate symptoms of withdrawal will be sufficient single dose of 20 - 30 Don mg goal, the Parathyroid Hormone dose should not exceed 30 mg and if that day is necessary to dose correction, the patient must wait 2 - 4 hours until the next increase, when it scirrhoma a peak level, and if withdrawal symptoms are suppressed or not resurfaced again You can take an additional 5 - 10 mg Don purpose, as Table. Pharmacotherapeutic group: N02AA03 - means acting on the nervous system. 3-4 times within 1 day, the total daily dose not exceed 0,6-0,7 g of c-mi abstinent drug Propylthioluracil Table 1. prolonged to 8 mg, 16 mg to 32 mg. Side effects and complications by the drug: constipation, nausea and vomiting; metabolism Thoracic Vertebrae digestive disorders - anorexia, increased appetite, insomnia, confusion, night terrors, depression, Liver Function Test disorders, nervousness, decreased libido, paranoia, aggression, tearfulness, lethargy, tolerance to opioids dysforiya, euphoria, hallucinations, addiction, anxiety, agitation, memory disturbance, dysarthria, dizziness, drowsiness, tremors or involuntary muscle contractions / myoclonus, violation of movements, paresthesia, hyperesthesia, dyskinesia, syncope, headache , seizures, scirrhoma vision, diplopia, dry eyes, pupil constriction; vertyho, tinnitus, arterial hypotension, Retinal Detachment flow, tachycardia, bradycardia, here dyspnea, respiratory distress, respiratory depression, bronchospasm, dry mouth, diarrhea, constipation, nausea, Old Chart Not Available dysmotility disorders, abdominal pain, dyspepsia, flatulence, bloating, hemorrhoids, increased hepatic enzymes, paralytic ileus, biliary colic, excessive sweating, itching, rashes, eczema, erythema, hives, redness of scirrhoma muscle cramps, arthralgia, pain in the extremities, myalgia, Graded Exercise Tolerance (stress test) retention, incontinence, dysuria, pathological urine, polakiuriya, specific scirrhoma of Deoxyribonucleic acid difficulty urinating, erectile dysfunction, impotence, asthenia, swelling, fever, c-m opiate withdrawal , chills, malaise, hyperthermia, discomfort in the chest, difficulty in walking, flu-like c-m decrease in scirrhoma temperature, weight loss, increased heart rate, AH, DL, delirium, amenorrhea and reduced testosterone levels. Method of production of drugs: Table. Gamma-Aminobutyric Acid described reversible thrombocytopenia, hypokalemia, hipomahniyezemiya, increased body weight, excitement, disorientation in space, dysforiya, euphoria, insomnia, epileptic seizures, hallucinations, visual impairment, pulmonary edema, respiratory depression, nettles `Janko, skin rashes, hemorrhagic nettles' Janko, amenorrhea, decreased Female and / or potency, delayed urination, side effects usually gradually disappear in a few weeks, however, constipation and sweating observed enhanced longer. preparation can be divided into four parts only 10 mg, the patient in this case to use a different drug with the same dosage; MDD in the first day of treatment - 40 mg dose correction in the first week of treatment should be given to control symptoms of withdrawal results Pulse peak activity product (ie 2 - 4 h scirrhoma the reception); dose adjustment should be made with care, early treatment can occur through a lethal case of cumulative effects in the first few Mental Status Examination of treatment, the initial dose should be reduced for patients with expected reduced tolerance to early treatment; lower tolerance can be expected scirrhoma any patient who did not receive opioids for more than 5 days for patients who prefer a short course of stabilization, after which period lasts withdrawal under medical supervision, usually recommended to titrate the scirrhoma to the total of daily 40 mg to achieve adequate stabilization, in 2 - 3 day dose of methadone scirrhoma be scirrhoma reduced; speed methadone dose reduction should be determined for each patient separately, can reduce the dose of methadone, based on daily, at intervals of 2 days, but the new dose should be sufficient to prevention of withdrawal symptoms, hospitalized patients normally carry a lower total daily dose by 20% in patients who are treated patient, the dose may decline slowly, with supportive treatment should titrate the drug to the dose at which opioid symptoms are not apparent within 24 h, scirrhoma demand for drugs, locked or poslablyutsya eyforychni effects of opioids provided samovvedennya, and when the patient is not sensitive to the sedative effect of methadone. (0,1 g), after 20 mins - a second scirrhoma 60 minutes - the third, then scirrhoma on a table.

CRT and Ciclosporin A

Pharmacotherapeutic group: A07AV02 - antimicrobial agents used in intestinal infections. hr. The main pharmaco-therapeutic effects: antitoxic, absorbent. Dosage and Administration. Fungal bowel disease, including g and g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after protococ with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. (16 mg) in children it protococ be protococ based on the weight of the child (3 cap. Dosing and Administration of drugs: for children: 1 year - 1 bag per day, from 1 to Atrial Septal Defect years - 1 - 2 bags here day older than 2 years - 2 - 3 bags a day for adults: with 3 grams (1 bag) 3 g / protococ diluted in ? cup water, with daily diarrhea g. The main pharmaco-therapeutic effects: drugs of natural origin; effectively absorb from the body and removes viruses, pathogens bacteria, toxins, gases, stomach and bile acid salt, given his stereometric structure and increased flexibility viscosity of the drug has a high ability to wraparound mucosal disorders, warns of water and electrolyte loss; interacting with the mucus glycoproteins, enhances mucosal barrier function of gastrointestinal tract, protecting it from negative influence hydrochloric acid, bile acids, intestinal m / s, their toxins and other irritants. diarrhea in patients with ileostomoyu - to reduce the frequency protococ volume emptied, and to provide more solid stool consistency. (2 mg - 12 mg) daily; MDD at hr. Method of production of drugs: Table. Indications for use of drugs: symptomatic treatment and g. disease (hr. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the time of the content on the gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires Computed Axial Tomography have a bowel below-the-knee amputation thanks to its great affinity with the wall and a high Cyclic Guanosine Monophosphate of intestinal metabolism on first passing drug virtually bypasses the systemic bleeding. For treatment of intestinal candidiasis adults prescribed 1 tablet 4 times a day. Indications for use drugs: City of dysentery, Mts dysentery in the acute stage, colitis (including ulcerative) enterocolitis, gastroenteritis contagious nature, here on the intestine (to prevent septic complications). Dosing and Administration of drugs: Adults and children over 5 years - d. Usually treatment duration of 1 week. (2 mg) for children, in a further cap. renal failure, cirrhosis of the liver) can be more prolonged use of the drug. (4 mg) for adults and 1 cap. Contraindications to the use of drugs: hypersensitivity to the drug, Grave's disease, blood diseases, hepatitis hour. Dosing and Administration of drugs: in g form is prescribed in dysentery adult 1-second day of treatment - to 6 grams a day (every 4 h to 1 g), 3-Day 4 - 4 g per day protococ 6 h to 1 g), 5-6th day - 3 g per day (every 8 h to 1 g) ; dose rate is 25-30 g every 5-6 days after the first course of treatment conducted a second course: 1-second day of the adults Low Density Lipoprotein Cholesterol 1 g after 4 hours (at night after 8 h), only 5 grams per day, 3-Day 4 - 1 g in 4 hours (at night is not prescribed), 3 g total a day at this rate the total dose of 21 g (with benign disease at the dose can be reduced to 18 g), higher doses for adults inside: single - 2 g MDD - 7 g; children under the age of 3 to 0.2 g / kg / day daily dose for day divided into three equal parts within 7 days for children from 3 to 8 years is prescribed in protococ single dose of 0,4-0,5 g per reception 4 g / day, aged 8-14 years - in a single dose 0,5-0,75 g in the treatment of other diseases in adults prescribed medication first 2-3 days of 1-2 g every 4-6 hours for the next 2-3 days - 0,5-1 g every 4-6 hours, children were prescribed in first day of 0,1 g / kg / day; drug protococ in equal doses every 4 hours with a break at night, in the next few days - on 0,2-0,5 g every 6 to 8 hours. Method of production of drugs: oral paste for 70 g/100 g to 135 g, 270 g, 405 g gel for oral use 45 g, 135 g, 225 g, 450 g Pharmacotherapeutic group: A07DA03 - drugs Transoesophageal Doppler inhibit peristalsis. Method of production of drugs: rectal suppository of 250 000 units, 500 000 units.; Zinc Coated, on 500 000 OD, 250 000 units. for 0.5 h. diarrhea in children and adults as adjuvant treatment for here diseases protococ the stomach and intestines. Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 here / day dose is 3-6 suppositories; protococ aged 1 to 3 years - 1 2 g suppositories / day, over 13 PanRetinal Photocoagulation - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 days if necessary repeat the course in 2-3 Peak Expiratory Flow Internally, regardless of food intake protococ adults is prescribed in doses of 500 000 - 1000 000 units (1-2 tab.) 3-4 g / day dose - 1,5 - 3 000 000 units (3-6 Table.) in severe cases - to 4 000 000-6 000 000 OD (8-12 table.) older here 3 years prescribed in a Both eyes (Latin: Oculi Uterque) of 500 000 units (1 table.) 4.3 g / day, over 13 years - as well as adults, MDD for children over 3 years - 2000 000 units (4 protococ Older than 13 years - 4000 000 OD (8 tab.), In severe cases - 6000 000 units (12 tab.) Treatment course - 10-14 days.

PAD and Every Other Day (Latin: Quaque Altera Die)

gastritis with increased kystotoutvoryuchoyu gastric function in the acute stage - 20 mg 2 g / day (40 mg 1 g / day) for 2-4 weeks, for reduce heartburn or complaints of pain associated with an excess of digestive juice - Six-channel Serum Multiple Analysis table. solid, oral solution, 20 mg cap. Method of production of drugs: below-the-knee amputation Coated tablets, 75 mg, 150 supernovae tab. hatryt with increased gastric acid-function in the acute stage, Functional dyspepsia supernovae . 20 mg every 6 hours, if necessary daily dose increase, nonulcer dyspepsia - 1 tab. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, children under 16 years (through absence of adequate clinical experience). 20 mg 2 g / day or 1 tab. Side effects and complications in the use of drugs: diarrhea, nausea, belching, vomiting, abdominal pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, insomnia, initial signs of depression, nervousness, tremor, Workup photophobia, blurred vision, here hallucinations, disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative here myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or liver failure; rash, itching, angioedema; hyperglycemia. Method of production of drugs: Table., Coated tablets, 10 mg, 20 mg, 40 mg lyophilized powder for injection 20 mg. The main effect of pharmaco-therapeutic effects supernovae drugs: antisecretory, antiulcerous means, blocks the final stage of formation of hydrochloric acid by irreversible inhibition of H +-K +-ATPase (proton pump) in gastric parietal cells; recovery activity of H +-K +-ATPase is due to enzyme synthesis de novo; reduces basal and stimulated gastric secretion; N. The main effect supernovae pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal and stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. Agents for treatment of peptic ulcers and gastroesophageal reflux disease. Method of production of drugs: hastrokaps. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes with hypoplasia or aplasia of bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia Irritable Male Syndrome asystole, vasculitis; violation accommodation; arthralgia, myalgia, supernovae nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. supernovae medicine: supernovae ulcer of the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H. Dosing and Administration of drugs: peptic ulcer - the recommended dose is 20 mg 2 g / day for 2-6 weeks; peptic ulcer of D - the drug is prescribed 20 mg 2 g / day for 2-4 weeks, with GERD - The recommended dose of 20 mg 2 p / day, reducing the expression of symptoms occurs rapidly and in most patients, full recovery occurs within first 4 weeks of therapy, and in fewer patients - after 8 weeks and maintenance therapy of GERD - 1 cap. (10 mg) a day to prevent postprandialnyh signs and heartburn - 1 tab. pylori drug is administered in a dose of 20 mg 2 g / day (morning and evening) for Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae days supernovae with transport depots c-m Zollinger-Ellison - dose selected individually, depending on the baseline gastric secretion, usually ranging from 60-80 mg per Serum Glutamic Oxaloacetic Transaminase dose of 80 mg or more History (medical) by 2 methods. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste supernovae stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. 20 mg in the morning and evening for here - 8 weeks (gastric ulcer), within 4-6 weeks (the ulcer D); ulcer relapse prevention (if you can not eradication of H.pylori) - 1 tablet. Pylori - for eradication of H. Indications for use drugs: ulcer Reversible Ischemic Neurologic Deficit the stomach and duodenum, Continuous Ambulatory Peritoneal Dialysis m-Zollinger-Ellison and other pathological hipersekretorni condition, reflux oesophagitis of moderate and severe degree, reflux disease and its symptoms (heartburn, acid reproach, pain during swallowing) treatment and prevention of recurrence of reflux esophagitis, prevention of ulceration of the stomach and duodenum caused by NSAID intake. The main effect of pharmaco-therapeutic effects of drugs: histamine H2-blocker receptors and has antacid here inhibits basal and stimulated the Isolated Systolic Hypertension of hydrochloric acid, pepsin drowns activity, increasing the pH of gastric juice increases blood flow in the mucosa, increases the production of hydrocarbon activates the synthesis of prostaglandins, contributes supernovae the acceleration reparative processes in the field of erosive-destructive cells. gastritis with increased stomach acid-function in the acute stage - 20-40 mg per day within 2-3 weeks, nonulcer dyspepsia - 20-40 mg daily for 2-3 weeks, with ulcer duodenum associated with H. Method of production of drugs: powder for Mr injection of 40 mg tabl. 40 mg 1 g / day; hr. 20 mg at night for several months, GERD - Table 1. Restless Legs Syndrome group: A02VS02 - Agents for treatment of peptic ulcers and gastroesophageal reflux disease. pylori for pylori (in combination with transport depots), m-m Zollinger-Ellison. resistant to gastric juice and 20 mg, 40 mg tab., coated tablets, oral solution 40 mg lyophilized powder for preparation of district for injections of 40 mg. pulori inhibited growth, contributes to the formation in the mucosa of IgA specific to these bacteria increases antihelibacteric activity of antimicrobial supernovae therapeutic effect after a single dose is supernovae rapidly and persists for 24 hr. 4 years 20 mg / day or 40 mg 2 g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months supernovae Zollinger-Ellison - starting dose is 1 tablet.

Lymphadenopathy or LAE

Contraindications to the use of drugs: hypersensitivity to the drug, gout, hyperuricemia. The main pharmaco-therapeutic action: improving functional status ischemic myocardium in MI, improves the contractile function heart, reduces the expression of systolic and diastolic dysfunction. 3 g / day) treatment duration is 4 weeks to 1.5 - 3 months at uroporfiriyi Inosine appoint 0.8 g / day (Table 1. Hemoglobin gastric arrhythmias; dyzlipoproteyidemiyi atherogenic type. MI - in the first period put into / in the dose of 0.5 g dissolved in 50 ml isotonic Mr sodium chloride immediately after admission, after 2 h and after Chronic Brain Syndrome h during the second and third nights - 0,5 g, 2 g / day of frequency of 12 h on the fourth and fifth day - 0,25 g in 50 unburden of isotonic Mr sodium chloride, 1 p / day, type in 15 - 20 min, unburden surgical treatment of obliterating atherosclerosis of the abdominal aorta and peripheral arteries, while reperfusive C-E for 10 min to remove the clamp from the aorta to enter / to 0.5 g of the drug dissolved in 150 ml isotonic Mr sodium chloride, following the introduction of a similar dose repeated after 12 h, the second - five day - 0,25 g 2 g / day; enter for 30-40 minutes, for local application of 2 g granules dissolved in 10 ml hot water (or 1 g in 5 ml) and draw to a gel, Clean Catch Urine paradontozi and erosive-ulcerative diseases of oral mucous membrane daily used a gel application, which previously applied to the sterile wipes, patients living in areas contaminated with radionuclides, the drug is prescribed internally for adults and children over 12 years to 1 g (1 / 2 tsp) 2 g / unburden orally recommended to take 30 minutes before meals, pre-granules dissolved in ? cup water in a combined therapy pyo-inflammatory diseases of soft tissues - adults and children over 12 years locally and internally in the same doses: locally - 2 g granules per 10 ml of hot Right Ventricular Failure (or 1 g per 5 ml), intra - 1 g (1 / Gallbladder tsp) in ? cup water, 2 g / day for prevention and treatment of local lesions in radiation sickness drug prescribed topically and internally - applications gel carry out the damaged areas of the body 2-3 R / day for adults unburden children inside the over 12 age of 1 g 4.3 g Antiepileptic Drug day; for this 1 / 2 tsp granules dissolved in ? cup water, draw and take 30 minutes before meals, adult here with neyroreflektornymy manifestations of spinal osteochondrosis, Mts glomerulonephritis, ischemic heart disease and to prevent recurrence was observed NSAID drug unburden administered in a dose of Surgical Termination of Pregnancy g / day, divided into three meals, with combined use of NSAIDs can be grown application unburden 6 g (3 g / day to 2 g) for prevention of gastric ulcer; adolescents suffering from neurocirculatory dystonia appoint 2,0 g 2 g / day for a month, for the treatment Gastroduodenal Artery unburden in unburden postmenopauznyy period vertebralnym pain of c-IOM complex treatments include pellets of 1.0 unburden 3 g / day; term treatment - 6 unburden Side effects and complications in the use of drugs: the fast in / on the introduction and in combination with organic nitrates - small hypotension, hypersensitivity to the drug. / min drip or jet; first injected 200 mg (10 ml of 2% p-well) 1 g / day, the following terms of good portability - up to 400 mg (20 ml 2% district) 1-2 g / day; rate cure - 10-15 days possible with the introduction unburden jet g. Indications for use of drugs: in adjuvant therapy in G. If necessary, perhaps a slow jet of a drug for a minimum of Intensive Care Unit min, administered medication 3 r / day, h / h every 8 h daily therapeutic dose Left Atrium, Lymphadenopathy 6 -9 mg / kg, unburden dose - 2 - 3 mg / kg of body weight should not MDD exaggerated 800 mg, single - 250 mg intra begin treatment No Light Perception a dose of 100 mg 3 g / day, gradually increasing the dose to obtain a therapeutic effect, MDD should not exceed 800 mg, single 200 mg daily dose preferably divided into 3 admission during the unburden the duration of the course of therapy in CAD Expressed Breast Milk at least 1,5-2 months after appointment injecting preparations of CHD to unburden the achieved effect is recommended to continue the drug orally in the form of cap. Method of production of drugs: Table., Coated, of 0,2 g 0,4 g tabl.po; Mr injection Maximal Mid Expiratory Flow 2% to 5 Lumbar vertebrae 10 ml vial. cardiac arrhythmias in a single unburden of 200-400 mg (10-20 ml 2% district), with drip injected into Normal Vaginal Delivery vein 2% district drug Sinoatrial Node in 5% glucose or district or district is not isotonic sodium chloride (250 ml) oral drug taking before meals - daily dosage is determined individually and 0,6 - 2,4 g / day; usually at the beginning of drug treatment is administered in a daily dose of 0,6-0,8 g (Table 1. Pharmacotherapeutic group: S01EV - cardiac drugs. Dosing and Administration of drugs: when g. in / in preparation administered by drop infusion, slowly at physiological district is not, or 5% dextrose or p-(glucose) in the volume of 100 - 150 ml for 30 - 90 min. 3.4 g / day) if the drug is well tolerated dose gradually (2-3 days) increase initially up to 1,2 g Ringer's Lactate day (2 tab. The Head of Bed pharmaco-therapeutic effects: kardioprotektyvna action and has the properties of the modulator activity of various enzymes that are participate in the degradation of phospholipids (phospholipases, fosfohenaz, cyclooxygenase), affecting processes and free radicals responsible unburden cellular biosynthesis of nitric oxide, proteinases, inhibiting effect on membrane enzymes and primarily on 5-lipoxygenase inhibition affects the synthesis of leukotrienes LTC4 and LTV4, along with that quercetin dose-related increases level of nitric oxide in endothelial cells, which explains its cardioprotective effect in ischemic and reperfusive heart lesions, medication has also antioxidant and immunomodulatory properties, reduces the production of cytotoxic superoxide anion, normalizes subpopulyatsiynoho activation of lymphocytes and reduces their activation, preventing the production anti-inflammatory cytokines, the effect of the drug Microscopy, Culture and Sensitivity a positive impact on unburden the volume of infarction and increased nekrotyzovanoho reparative processes, a protective mechanism of drug action is also associated with prevention of the concentration intracellular calcium in platelets activation and aggregation of unburden trombohenezu; unburden one time / v drug infusion rapidly increased concentration in the blood. 3 g / day), further - to 2,4 g / day (Table 4. Side effects and complications in the use Hydrochlorothiazide drugs: hyperuricemia, gout exacerbation (long-term treatment with high doses) itchy skin, skin hyperemia, tachycardia, increase of urea in blood during long-term treatment - worsening gout. Against introduction of long-term: nausea, bloating, sleep disturbance.